Living Homeopathy International Ltd. (LHI)

Living Homeopathy International will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$4.00 - $6.00

Shares Offered

1,250,000

Deal Size

$6.25M

LHI Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Revenue	8.19	8.51	9.16
Revenue Growth (YoY)	-	-7.12%	-
Cost of Revenue	-	2.13	2.3
Gross Profit	6.11	6.38	6.86
Selling, General & Admin	-	5.09	5.21
Other Operating Expenses	0	0.36	0.36
Operating Expenses	-	5.45	5.57
Operating Income	0.33	0.93	1.29
Interest Expense / Income	0.06	0.07	0.05
Other Expense / Income	-0.04	-0.04	-0.09
Pretax Income	0.3	0.9	1.33
Income Tax	0.1	0.14	0.21
Net Income	0.2	0.75	1.13
Net Income Growth	-	-33.30%	-
Free Cash Flow	0.75	0.69	1.4
Gross Margin	74.59%	74.98%	74.91%
Operating Margin	4.02%	10.89%	14.12%
Profit Margin	2.44%	8.85%	12.33%
Free Cash Flow Margin	9.12%	8.08%	15.32%
Effective Tax Rate	34.01%	15.82%	15.37%
EBITDA	0.43	1.06	1.47
EBITDA Margin	5.26%	12.41%	16.09%
Depreciation & Amortization	0.06	0.09	0.09
EBIT	0.37	0.97	1.39
EBIT Margin	4.47%	11.40%	15.15%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).